Followers | 2 |
Posts | 62 |
Boards Moderated | 0 |
Alias Born | 07/02/2013 |
Monday, December 14, 2020 2:59:06 PM
Our CEO wrote a letter to personally thank all of you for supporting us along our journey as we complete enrollment for our multinational Phase 2b/3 trial of Ifenprodil for #COVID-19.
— Algernon Pharmaceuticals (@AlgernonPharma) December 14, 2020
We invite you to read the letter on our website.$AGN.CN $AGW $AGNPFhttps://t.co/hLrLXvYqef
Learn about Ifenprodil’s potential to become a leading therapeutic treatment in our featured @BNNBloomberg article.#AGNMultinationalTrial$AGN.CN $AGW $AGNPF #Stockshttps://t.co/sUwf1zq5Pm
— Algernon Pharmaceuticals (@AlgernonPharma) December 14, 2020
interesting choices of tweets today
Maybacks Global Entertainment and ZEASN Technology Private Ltd. Sign Global Licensing Agreement • AHRO • Aug 8, 2024 7:00 AM
SANUWAVE Will Host a Conference Call on August 13, 2024 at 8:30 AM (ET) to Present Q2 Financial Results • SNWV • Aug 8, 2024 6:59 AM
Kona Gold Beverage Inc. Signs Letter of Intent with Bemax, Inc. to Sell Kona Gold, LLC • BMXC • Aug 7, 2024 10:00 AM
Btab Ecommerce Group, Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • BBTT • Aug 7, 2024 9:00 AM
Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business Update • HYDI • Aug 7, 2024 8:52 AM
North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • NBRI • Aug 5, 2024 9:00 AM